文献速递前列腺增生与排尿功能障碍

既往前列腺干预后钬激光前列腺剜除术的可行性

Feasibility of Holmium Laser Enucleation of the Prostate After Prior Prostate Intervention for Benign Prostatic Hyperplasia.
PubMed 文献 · Urology · 2025-12-06

回顾性分析2015年8月至2025年2月单中心1876例HoLEP,其中143例有前列腺手术史,按前列腺重量1:1匹配143例无手术史者。既往手术组剜除效率、血红蛋白下降及IPSS结局无显著差异,但粉碎效率降低、估计出血量更高。HoLEP在初治与再治疗中均安全有效。

要点

  • 既往前列腺手术史不影响HoLEP的剜除效率与IPSS改善。
  • 既往手术组粉碎效率降低且估计出血量更高。
  • HoLEP可作为BPH初治与再治疗的安全有效选择。

核心结论

  • HoLEP在初治和再治疗BPH中均安全有效,既往干预不影响剜除效率、血红蛋白下降或IPSS结局,但降低粉碎效率并增加出血。

研究设计与样本

  • 回顾性分析2015年8月至2025年2月德克萨斯州三级中心前瞻性维护数据库,1876例HoLEP中143例有前列腺手术史,按前列腺重量1:1匹配143例无手术史者,共286例。

主要发现

  • 既往手术组最常见术式为TURP(82例)。
  • 两组术前IPSS、年龄、切除重量、剜除效率、血红蛋白下降及前列腺体积无显著差异。
  • 术后3个月既往手术组IPSS显著更低。
  • 既往手术组粉碎效率降低且估计出血量更高。
  • 两组IPSS总体均显著改善。

临床怎么用

  • 对既往接受前列腺手术的BPH患者,HoLEP可安全实施且剜除效率与功能结局与初治者相当。
  • 需预期既往手术者粉碎效率降低和出血量增加,术中应加强止血并优化粉碎操作。

局限性

  • 回顾性设计,单中心三级医院数据。
  • 样本量有限(既往手术组143例),匹配仅基于前列腺重量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and outcomes of holmium laser enucleation of the prostate (HoLEP) in patients with a history of prior surgical prostate intervention, and to compare these results with the patients without previous prostate intervention. METHODS: A retrospective review of a prospectively maintained database at a tertiary-level center in Texas. From August 2015 to February 2025, 1876 patients underwent HoLEP, 143 had previous prostate surgery. These were matched 1:1 with 143 patients without prior surgery based on prostate weight. Data included IPSS, hemoglobin reduction, resected tissue weight, enucleation and morcellation efficacy, prostate volume, and estimated blood loss (EBL). RESULTS: A total of 286 patients. Of 143 patients with prior surgery, TURP was the most common procedure (82 cases). No significant differences were found between groups in preoperative IPSS, age, resected weight, enucleation efficacy, hemoglobin reduction, or prostate volume. At 3 months postoperatively, the IPSS was significantly lower in patients with prior surgery. Morcellation efficacy was reduced, and EBL was higher in the prior surgery group. Both groups demonstrated significant improvements in IPSS overall. CONCLUSION: HoLEP is a safe and effective surgical option for BPH in both primary and re-treatment settings. Prior interventions do not significantly affect enucleation efficacy, hemoglobin reduction, or IPSS outcomes; however, they are associated with reduced morcellation efficiency and increased blood loss.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Mokhtarzadehazar P, Ferguson B, Davis G, et al. Feasibility of Holmium Laser Enucleation of the Prostate After Prior Prostate Intervention for Benign Prostatic Hyperplasia. Urology. 2025. PMID: 41360301. doi:10.1016/j.urology.2025.11.248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。